Lessons about Botulinum Toxin A Therapy from Cervical Dystonia Patients Drawing the Course of Disease: A Pilot Study.

Harald HefterIsabelle SchomaeckerMax SchomaeckerBeyza ÜrerRaphaela BraunsDietmar RosenthalPhilipp AlbrechtSara Samadzadeh

Published in: Toxins (2023)

Patients' drawings of their course of disease severity helps to easily detect "difficult to treat" primary and secondary nonresponders to BoNT on the one hand, but also to detect "golden responders" on the other hand.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
stem cells
patient reported
smoking cessation